TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PANACEA

CardiovascularNeurology
Generics

PANACEA is a generic drug manufacturer focused on Cardiovascular, Neurology.

2012
Since
3
Drugs
-
Trials
32
Approved (2yr)

Key Drugs

PRASUGREL
prasugrel hydrochloride
Cardiovascular
P2Y12 7 indications · 2017

Recent Activity

TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-10-17
Labeling
TACROLIMUS 2025-09-26
Labeling
TACROLIMUS 2025-09-26
Labeling
TACROLIMUS 2025-09-04
Labeling
TACROLIMUS 2025-05-19
Labeling
TACROLIMUS 2025-05-19
Labeling
TACROLIMUS 2025-05-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Neurology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

GE HEALTHCARE specialty
Neurology, Cardiovascular
Novo Nordisk big-pharma
Cardiovascular, Neurology
LEDERLE big-pharma
Cardiovascular, Neurology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular
VALIDUS PHARMS specialty
Cardiovascular, Neurology